17 Sep 2025 | 3 Mins Read
Lupin shares plummet after USFDA issues Nagpur plant observations
Flipitmoney
Lupin Ltd shares fell 0.81% after USFDA issued six observations for its Nagpur injectable facility following a September 8-16 inspection. Lupin must address and respond to the observations within the required timeline. This news comes after the company secured USFDA approval for Risperidone Injectable.